Tyra Biosciences
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -138 | -132 | ||
EBITDA | -45,420 | -39,167 | -33,702 | -29,737 |
EBIT | -45,558 | -39,305 | -33,834 | -29,868 |
Net Income | -45,558 | -39,305 | -33,834 | -29,868 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -31,142 | -32,659 | -23,681 | -22,419 |
Cash | 73,835 | 84,955 | 77,387 | 61,951 |
Basic Shares | 65,991 | 61,746 | 59,602 | 59,670 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -546 | -519 | -353 | -296 |
EBITDA | -119,401 | -85,962 | -68,777 | -58,631 |
EBIT | -119,947 | -86,481 | -69,134 | -58,927 |
Net Income | -119,947 | -86,481 | -69,134 | -51,723 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -50,212 | |||
Free Cash Flow | -95,283 | -70,438 | -50,909 | -50,844 |
Cash | 77,387 | 91,966 | 58,006 | 251,213 |
Basic Shares | 59,602 | 57,217 | 42,704 | 41,883 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.69 |
2026-03-31 | -$0.64 |
2025-12-31 | -$0.57 |
2025-09-30 | -$0.50 |